Yale Study: First Nicotine Product Tried Correlates With Current Product Use and Nicotine Dependence in Youth
Young people who use smokeless tobacco as their first nicotine product may be more likely to try other nicotine products and develop nicotine dependence, according to a new study by Yale researchers. Patricia Simon, PhD, assistant professor adjunct of psychiatry, is the study's first author.Source: Preventive Medicine
Bold Receives Grant to Study Impact of Menthol Flavor Ban in Cigarettes and E-cigarettes
Krysten Bold, PhD, assistant professor of psychiatry, has received an R01 grant from the National Institute on Drug Abuse (NIDA) to study the impact of a menthol flavor ban in cigarettes and e-cigarettes to inform tobacco policy.
VA/Yale Researchers Lead Multi-ancestry Study of Genetics of Problematic Alcohol Use
A study led by VA Connecticut Healthcare Center/Yale researchers reveals ancestries around the world possess a shared genetic architecture for problematic alcohol use – habitual heavy drinking, accompanied by harmful consequences. Hang Zhou, PhD, assistant professor of psychiatry and of biomedical informatics & data science at Yale School of Medicine and VA Connecticut, and Joel Gelernter, MD, Foundations Fund Professor of Psychiatry, and professor of genetics and of neuroscience at Yale School of Medicine and VA Connecticut, were first and senior authors, respectively.
VA/Yale Researchers Lead Study That Assesses Well-being of U.S. Veterans
A new study led by the National Center for PTSD and Yale researchers analyzed data from a nationally representative sample of more than 2,400 U.S. veterans to examine subjective ratings and key sociodemographic, health, and psychosocial correlates of well-being. Peter Jongho Na, MD, MPH, and Robert Pietrzak, PhD, MPH, were lead and senior authors of the study, published in JAMA Network Open.
What the Streets Teach
Emma Lo, MD, assistant professor of psychiatry, is medical director of the Street Psychiatry Team at the Connecticut Mental Health Center. She began advocating for people who were experiencing homelessness while in medical school at the University of Rochester School of Medicine and Dentistry, where she founded a street outreach program.Source: Rochester Medicine
Readiness For Change: Assessing Employee Commitment to Peer Worker Integration in Drug Court Settings
Brandee M. Izquierdo, DPA, MPA, lecturer in psychiatry, and Chyrell Bellamy, PhD, MSW, professor of psychiatry, are first and senior authors, respectively, of a paper in Journal of Offender Rehabilitation that assesses drug court employees’ readiness and perceived commitment to peer worker integration.Source: Journal of Offender Rehabilitation
Neural Patterns Differentiate Traumatic From Sad Autobiographical Memories in PTSD
Investigators from Yale and Mount Sinai schools of medicine studied the neural activity of 28 people diagnosed with post-traumatic stress disorder (PTSD). They found that autobiographical memories for sad and neutral memories are processed differently in the brain than for traumatic memories. The findings were published in Nature Neuroscience. The co-senior author is Ilan Harpaz-Rotem, PhD, professor of psychiatry and of psychology at Yale School of Medicine.
The Effect of 10 Versus 20 Minutes of Mindfulness Meditation on State Mindfulness and Affect
Hedy Kober, PhD, associate professor of psychiatry and of psychology, is senior author of a paper in Scientific Reports that found a single session of mindfulness meditation improves state mindfulness regardless of whether sessions are 10 or 20 minutes long.Source: Scientific Reports
PRCH Publishes Special Journal Issue to Celebrate 10th Anniversary of IRCC
The Yale Program for Recovery and Community Health published a special edition of the Journal of Public Mental Health to mark the 10th anniversary of the International Recovery and Citizenship Collective. Guest editors are Chyrell Bellamy, PhD, MSW; Graziela Reis, MPH; Helen Hamer, PhD, RN; and Gillian MacIntyre, PhD.Source: Journal of Public Mental Health
What to Know About Treating Seasonal Affective Disorder
Paul Desan, PhD, associate professor of psychiatry and director of the Winter Depression Research Clinic at Yale School of Medicine, spoke to PBS News about why some people suffer from Seasonal Affective Disorder, or SAD, a recurrent form of depression that emerges in the winter.Source: PBS News
Ketamine and the Neurobiology of Depression: Toward Next-generation Rapid-acting Antidepressant Treatments
John Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research and Professor of Psychiatry, of Neuroscience, and of Psychology; and Irina Esterlis, PhD, associate professor of psychiatry, are first and senior authors, respectively, of a review published in Proceedings of the National Academy of Sciences Perspective that considers what scientists have learned from studies of ketamine and to suggest future directions for the optimization of rapid-acting antidepressant treatment.Source: Proceedings of the National Academy of Sciences Perspective
Sanacora, Wilkinson Receive $12.6M in Funding for Ketamine Study
Gerard Sanacora, MD, PhD (left), George D. and Esther S. Gross Professor of Psychiatry, and Samuel Wilkinson, MD, associate professor of psychiatry, have received $12.6 million in funding from the Patient-Centered Outcomes Research Institute (PCORI) for the study, “Comparative Effectiveness of Racemic Ketamine versus S-Ketamine (Spravato) for Depression.”
Ukrainian Widows, Children Process Trauma Through Mountain Climbing in Austrian Alps
Amit Oren, PhD, assistant clinical professor of psychology in psychiatry, was featured in a 60 Minutes Overtime report on a climbing camp in the Austrian Alps for Ukrainian widows and children. The camp is sponsored by Mountain Seed Foundation, a Virginia-based organization founded by an American veteran which works to heal children and families from war-torn countries like Ukraine. While the children climbed, Oren worked with the mothers on self-care during times of crisis and how to cope with long term uncertainty. "The way I approach this group of people is not in looking at their trauma. It's in looking at their strengths," she told 60 Minutes Overtime journalist Scott Pelley.Source: 60 Minutes Overtime
Supplying a High: Nitrous Oxide Abuse Chokes With Colorful and Dangerous Highs
Amir Garakani, MD, associate professor of psychiatry and chair of psychiatry and behavioral health at Greenwich Hospital, spoke to WVUE-Fox 8 about the potential health risks associated with frequent nitrous oxide use.Source: WVUE-Fox 8
PRCH Representatives Collaborate With City, Local Artist to Create Mural in New Haven
Representatives of the Yale Program for Recovery and Community Health (PRCH) and the City of New Haven’s Office of Community Mental Initiatives worked with an artist to create a 50-foot mural at the corner of Blatchley and Grand avenues in New Haven.
Multi-ancestry Genome-wide Association Study of Cannabis Use Disorder Yields Insight Into Disease Biology and Public Health Implications
In a landmark research study, scientists have unveiled the results of a comprehensive genome-wide association study (GWAS), published in Nature Genetics, shedding new light on the genetic factors underlying cannabis use disorders (CanUD) and their potential link to lung cancer.
Yale Psychiatry Researchers Awarded Grant to Establish PRISM Initiative
Yale Department of Psychiatry researchers have been awarded a three-year federal grant to establish the Partnered Evaluation of Relationship Health Innovations and Services through Mixed Methods (PRISM) Initiative. Galina Portnoy, PhD, assistant professor of psychiatry, is the principal investigator on the PRISM Initiative, a $1.63 million grant supported by the Quality Enhancement Research Initiative (QUERI) and VA’s Care Management and Social Work Service Intimate Partner Violence Assistance Program (IPVAP).
Ketamine Effectively Treats Depression. Do the Benefits Outweigh the Risks?
Sophie Holmes, PhD, assistant professor of psychiatry, told National Geographic that continued research is needed to determine who might benefit from being treated by ketamine, the drug often prescribed in cases of severe depression and anxiety.Source: National Geographic